Last reviewed · How we verify

NCT05869890

Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi

Terminated NA Last updated 21 February 2025
What this trial tests

NA trial testing MOSES laser system in Renal Calculi in 2 participants. Terminated before completion.

Timeline
22 February 2023
Primary endpoint
27 August 2024
27 August 2024

Quick facts

Lead sponsorAlbany Medical College
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment2
Start date22 February 2023
Primary completion27 August 2024
Estimated completion27 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Albany Medical College

Who can join

Adults 18 to 80, any sex, with Renal Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the effects of ureteroscopic lasing technique (dusting, fragmentation and a hybrid approach) on total lasing time and total energy in patients with a large renal calculi burden of single or multiple stones with the sum of its longest diameters between 10-20 mm and having mean Hounsfield units of 1000 or more.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Renal Calculi

Currently open trials in the same condition.

Other Albany Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869890.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing